Global Phage Therapy Market Growth (Status and Outlook) 2021-2026

Global Phage Therapy Market Growth (Status and Outlook) 2021-2026

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Phage Therapy Market Size 2016-2026
2.1.2 Phage Therapy Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Phage Therapy Segment by Type
2.2.1 DsDNA Bacteriophage
2.2.2 DsDNA Bacteriophage
2.2.3 SsRNA Bacteriophage
2.2.4 Others
2.3 Phage Therapy Market Size by Type
2.3.1 Global Phage Therapy Market Size CAGR by Type
2.3.2 Global Phage Therapy Market Size Market Share by Type (2016-2021)
2.4 Phage Therapy Segment by Application
2.4.1 Animal Health
2.4.2 Aquaculture
2.4.3 Agriculture
2.4.4 Food Industry
2.4.5 Human Health
2.4.6 Others
2.5 Phage Therapy Market Size by Application
2.5.1 Global Phage Therapy Market Size CAGR by Application
2.5.2 Global Phage Therapy Market Size Market Share by Application (2016-2021)

3 Phage Therapy Market Size by Players
3.1 Phage Therapy Market Size Market Share by Players
3.1.1 Global Phage Therapy Revenue by Players (2019-2021E)
3.1.2 Global Phage Therapy Revenue Market Share by Players (2019-2021E)
3.2 Global Phage Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Phage Therapy by Regions
4.1 Phage Therapy Market Size by Regions (2016-2021)
4.2 Americas Phage Therapy Market Size Growth (2016-2021)
4.3 APAC Phage Therapy Market Size Growth (2016-2021)
4.4 Europe Phage Therapy Market Size Growth (2016-2021)
4.5 Middle East & Africa Phage Therapy Market Size Growth (2016-2021)

5 Americas
5.1 Americas Phage Therapy Market Size by Country (2016-2021)
5.2 Americas Phage Therapy Market Size by Type (2016-2021)
5.3 Americas Phage Therapy Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Phage Therapy Market Size by Region (2016-2021)
6.2 APAC Phage Therapy Market Size by Type (2016-2021)
6.3 APAC Phage Therapy Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Phage Therapy by Country (2016-2021)
7.2 Europe Phage Therapy Market Size by Type (2016-2021)
7.3 Europe Phage Therapy Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Phage Therapy by Region (2016-2021)
8.2 Middle East & Africa Phage Therapy Market Size by Type (2016-2021)
8.3 Middle East & Africa Phage Therapy Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Phage Therapy Market Forecast
10.1 Global Phage Therapy Forecast by Regions (2021-2026)
10.1.1 Global Phage Therapy Forecast by Regions (2021-2026)
10.1.2 Americas Phage Therapy Forecast
10.1.3 APAC Phage Therapy Forecast
10.1.4 Europe Phage Therapy Forecast
10.1.5 Middle East & Africa Phage Therapy Forecast
10.2 Americas Phage Therapy Forecast by Countries (2021-2026)
10.2.1 United States Phage Therapy Market Forecast
10.2.2 Canada Phage Therapy Market Forecast
10.2.3 Mexico Phage Therapy Market Forecast
10.2.4 Brazil Phage Therapy Market Forecast
10.3 APAC Phage Therapy Forecast by Region (2021-2026)
10.3.1 China Phage Therapy Market Forecast
10.3.2 Japan Phage Therapy Market Forecast
10.3.3 Korea Phage Therapy Market Forecast
10.3.4 Southeast Asia Phage Therapy Market Forecast
10.3.5 India Phage Therapy Market Forecast
10.3.6 Australia Phage Therapy Market Forecast
10.4 Europe Phage Therapy Forecast by Country (2021-2026)
10.4.1 Germany Phage Therapy Market Forecast
10.4.2 France Phage Therapy Market Forecast
10.4.3 UK Phage Therapy Market Forecast
10.4.4 Italy Phage Therapy Market Forecast
10.4.5 Russia Phage Therapy Market Forecast
10.5 Middle East & Africa Phage Therapy Forecast by Region (2021-2026)
10.5.1 Egypt Phage Therapy Market Forecast
10.5.2 South Africa Phage Therapy Market Forecast
10.5.3 Israel Phage Therapy Market Forecast
10.5.4 Turkey Phage Therapy Market Forecast
10.5.5 GCC Countries Phage Therapy Market Forecast
10.6 Global Phage Therapy Forecast by Type (2021-2026)
10.7 Global Phage Therapy Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 NPO Microgen
11.1.1 NPO Microgen Company Information
11.1.2 NPO Microgen Phage Therapy Product Offered
11.1.3 NPO Microgen Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 NPO Microgen Main Business Overview
11.1.5 NPO Microgen Latest Developments
11.2 Proteon Pharmaceuticals
11.2.1 Proteon Pharmaceuticals Company Information
11.2.2 Proteon Pharmaceuticals Phage Therapy Product Offered
11.2.3 Proteon Pharmaceuticals Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Proteon Pharmaceuticals Main Business Overview
11.2.5 Proteon Pharmaceuticals Latest Developments
11.3 Phagelux
11.3.1 Phagelux Company Information
11.3.2 Phagelux Phage Therapy Product Offered
11.3.3 Phagelux Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Phagelux Main Business Overview
11.3.5 Phagelux Latest Developments
11.4 Intralytix
11.4.1 Intralytix Company Information
11.4.2 Intralytix Phage Therapy Product Offered
11.4.3 Intralytix Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Intralytix Main Business Overview
11.4.5 Intralytix Latest Developments
11.5 Micreos
11.5.1 Micreos Company Information
11.5.2 Micreos Phage Therapy Product Offered
11.5.3 Micreos Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Micreos Main Business Overview
11.5.5 Micreos Latest Developments
11.6 Eliava BioPreparations
11.6.1 Eliava BioPreparations Company Information
11.6.2 Eliava BioPreparations Phage Therapy Product Offered
11.6.3 Eliava BioPreparations Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Eliava BioPreparations Main Business Overview
11.6.5 Eliava BioPreparations Latest Developments
11.7 Locus Biosciences,Inc
11.7.1 Locus Biosciences,Inc Company Information
11.7.2 Locus Biosciences,Inc Phage Therapy Product Offered
11.7.3 Locus Biosciences,Inc Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Locus Biosciences,Inc Main Business Overview
11.7.5 Locus Biosciences,Inc Latest Developments
11.8 Pharmex Group,LLC
11.8.1 Pharmex Group,LLC Company Information
11.8.2 Pharmex Group,LLC Phage Therapy Product Offered
11.8.3 Pharmex Group,LLC Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Pharmex Group,LLC Main Business Overview
11.8.5 Pharmex Group,LLC Latest Developments
11.9 Pherecydes Pharma
11.9.1 Pherecydes Pharma Company Information
11.9.2 Pherecydes Pharma Phage Therapy Product Offered
11.9.3 Pherecydes Pharma Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Pherecydes Pharma Main Business Overview
11.9.5 Pherecydes Pharma Latest Developments
11.10 APS Biocontrol Ltd. (APS)
11.10.1 APS Biocontrol Ltd. (APS) Company Information
11.10.2 APS Biocontrol Ltd. (APS) Phage Therapy Product Offered
11.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 APS Biocontrol Ltd. (APS) Main Business Overview
11.10.5 APS Biocontrol Ltd. (APS) Latest Developments
11. Qingdao Phagepharm Bio-tech
11.11.1 Qingdao Phagepharm Bio-tech Company Information
11.11.2 Qingdao Phagepharm Bio-tech Phage Therapy Product Offered
11.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Qingdao Phagepharm Bio-tech Main Business Overview
11.11.5 Qingdao Phagepharm Bio-tech Latest Developments
11.12 Fixed-Phage Limited
11.12.1 Fixed-Phage Limited Company Information
11.12.2 Fixed-Phage Limited Phage Therapy Product Offered
11.12.3 Fixed-Phage Limited Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Fixed-Phage Limited Main Business Overview
11.12.5 Fixed-Phage Limited Latest Developments
11.13 Zeptometrix
11.13.1 Zeptometrix Company Information
11.13.2 Zeptometrix Phage Therapy Product Offered
11.13.3 Zeptometrix Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Zeptometrix Main Business Overview
11.13.5 Zeptometrix Latest Developments
11.14 Phage International, Inc.
11.14.1 Phage International, Inc. Company Information
11.14.2 Phage International, Inc. Phage Therapy Product Offered
11.14.3 Phage International, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Phage International, Inc. Main Business Overview
11.14.5 Phage International, Inc. Latest Developments
11.15 MicroMir
11.15.1 MicroMir Company Information
11.15.2 MicroMir Phage Therapy Product Offered
11.15.3 MicroMir Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 MicroMir Main Business Overview
11.15.5 MicroMir Latest Developments
11.16 iNtODEWORLD, Inc.
11.16.1 iNtODEWORLD, Inc. Company Information
11.16.2 iNtODEWORLD, Inc. Phage Therapy Product Offered
11.16.3 iNtODEWORLD, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 iNtODEWORLD, Inc. Main Business Overview
11.16.5 iNtODEWORLD, Inc. Latest Developments
11.17 NEXTBIOTICS
11.17.1 NEXTBIOTICS Company Information
11.17.2 NEXTBIOTICS Phage Therapy Product Offered
11.17.3 NEXTBIOTICS Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.17.4 NEXTBIOTICS Main Business Overview
11.17.5 NEXTBIOTICS Latest Developments
11.18 Armata Pharmaceuticals, Inc.
11.18.1 Armata Pharmaceuticals, Inc. Company Information
11.18.2 Armata Pharmaceuticals, Inc. Phage Therapy Product Offered
11.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.18.4 Armata Pharmaceuticals, Inc. Main Business Overview
11.18.5 Armata Pharmaceuticals, Inc. Latest Developments
11.19 Innophage
11.19.1 Innophage Company Information
11.19.2 Innophage Phage Therapy Product Offered
11.19.3 Innophage Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.19.4 Innophage Main Business Overview
11.19.5 Innophage Latest Developments
11.20 Adaptive Phage Therapeutics
11.20.1 Adaptive Phage Therapeutics Company Information
11.20.2 Adaptive Phage Therapeutics Phage Therapy Product Offered
11.20.3 Adaptive Phage Therapeutics Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.20.4 Adaptive Phage Therapeutics Main Business Overview
11.20.5 Adaptive Phage Therapeutics Latest Developments
11.21 TechnoPhage
11.21.1 TechnoPhage Company Information
11.21.2 TechnoPhage Phage Therapy Product Offered
11.21.3 TechnoPhage Phage Therapy Revenue, Gross Margin and Market Share (2019-2021)
11.21.4 TechnoPhage Main Business Overview
11.21.5 TechnoPhage Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Phage Therapy Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of DsDNA Bacteriophage
Table 3. Major Players of SsDNA Bacteriophage
Table 4. Major Players of SsRNA Bacteriophage
Table 5. Major Players of Others
Table 6. Phage Therapy Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 7. Global Phage Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 8. Global Phage Therapy Market Size Market Share by Type (2016-2021)
Table 9. Phage Therapy Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 10. Global Phage Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 11. Global Phage Therapy Market Size Market Share by Application (2016-2021)
Table 12. Global Phage Therapy Revenue by Players (2019-2021E) & ($ Millions)
Table 13. Global Phage Therapy Revenue Market Share by Players (2019-2021E)
Table 14. Phage Therapy Key Players Head office and Products Offered
Table 15. Phage Therapy Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Phage Therapy Market Size by Regions 2016-2021 & ($ Millions)
Table 19. Global Phage Therapy Market Size Market Share by Regions 2016-2021
Table 20. Americas Phage Therapy Market Size by Country (2016-2021) & ($ Millions)
Table 21. Americas Phage Therapy Market Size Market Share by Country (2016-2021)
Table 22. Americas Phage Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 23. Americas Phage Therapy Market Size Market Share by Type (2016-2021)
Table 24. Americas Phage Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 25. Americas Phage Therapy Market Size Market Share by Application (2016-2021)
Table 26. APAC Phage Therapy Market Size by Region (2016-2021) & ($ Millions)
Table 27. APAC Phage Therapy Market Size Market Share by Region (2016-2021)
Table 28. APAC Phage Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 29. APAC Phage Therapy Market Size Market Share by Type (2016-2021)
Table 30. APAC Phage Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 31. APAC Phage Therapy Market Size Market Share by Application (2016-2021)
Table 32. Europe Phage Therapy Market Size by Country (2016-2021) & ($ Millions)
Table 33. Europe Phage Therapy Market Size Market Share by Country (2016-2021)
Table 34. Europe Phage Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 35. Europe Phage Therapy Market Size Market Share by Type (2016-2021)
Table 36. Europe Phage Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 37. Europe Phage Therapy Market Size Market Share by Application (2016-2021)
Table 38. Middle East & Africa Phage Therapy Market Size by Region (2016-2021) & ($ Millions)
Table 39. Middle East & Africa Phage Therapy Market Size Market Share by Region (2016-2021)
Table 40. Middle East & Africa Phage Therapy Market Size by Type (2016-2021) & ($ Millions)
Table 41. Middle East & Africa Phage Therapy Market Size Market Share by Type (2016-2021)
Table 42. Middle East & Africa Phage Therapy Market Size by Application (2016-2021) & ($ Millions)
Table 43. Middle East & Africa Phage Therapy Market Size Market Share by Application (2016-2021)
Table 44. Key and Potential Regions of Phage Therapy
Table 45. Key Application and Potential Industries of Phage Therapy
Table 46. Key Challenges of Phage Therapy
Table 47. Key Trends of Phage Therapy
Table 48. Global Phage Therapy Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 49. Global Phage Therapy Market Size Market Share Forecast by Regions (2021-2026)
Table 50. Global Phage Therapy Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 51. Global Phage Therapy Market Size Market Share Forecast by Type (2021-2026)
Table 52. Global Phage Therapy Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 53. Global Phage Therapy Market Size Market Share Forecast by Application (2021-2026)
Table 54. NPO Microgen Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 55. NPO Microgen Phage Therapy Product Offered
Table 56. NPO Microgen Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 57. NPO Microgen Main Business
Table 58. NPO Microgen Latest Developments
Table 59. Proteon Pharmaceuticals Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 60. Proteon Pharmaceuticals Phage Therapy Product Offered
Table 61. Proteon Pharmaceuticals Main Business
Table 62. Proteon Pharmaceuticals Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 63. Proteon Pharmaceuticals Latest Developments
Table 64. Phagelux Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 65. Phagelux Phage Therapy Product Offered
Table 66. Phagelux Main Business
Table 67. Phagelux Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 68. Phagelux Latest Developments
Table 69. Intralytix Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 70. Intralytix Phage Therapy Product Offered
Table 71. Intralytix Main Business
Table 72. Intralytix Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 73. Intralytix Latest Developments
Table 74. Micreos Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 75. Micreos Phage Therapy Product Offered
Table 76. Micreos Main Business
Table 77. Micreos Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 78. Micreos Latest Developments
Table 79. Eliava BioPreparations Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 80. Eliava BioPreparations Phage Therapy Product Offered
Table 81. Eliava BioPreparations Main Business
Table 82. Eliava BioPreparations Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 83. Eliava BioPreparations Latest Developments
Table 84. Locus Biosciences,Inc Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 85. Locus Biosciences,Inc Phage Therapy Product Offered
Table 86. Locus Biosciences,Inc Main Business
Table 87. Locus Biosciences,Inc Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 88. Locus Biosciences,Inc Latest Developments
Table 89. Pharmex Group,LLC Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 90. Pharmex Group,LLC Phage Therapy Product Offered
Table 91. Pharmex Group,LLC Main Business
Table 92. Pharmex Group,LLC Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 93. Pharmex Group,LLC Latest Developments
Table 94. Pherecydes Pharma Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 95. Pherecydes Pharma Phage Therapy Product Offered
Table 96. Pherecydes Pharma Main Business
Table 97. Pherecydes Pharma Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 98. Pherecydes Pharma Latest Developments
Table 99. APS Biocontrol Ltd. (APS) Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 100. APS Biocontrol Ltd. (APS) Phage Therapy Product Offered
Table 101. APS Biocontrol Ltd. (APS) Main Business
Table 102. APS Biocontrol Ltd. (APS) Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 103. APS Biocontrol Ltd. (APS) Latest Developments
Table 104. Qingdao Phagepharm Bio-tech Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 105. Qingdao Phagepharm Bio-tech Phage Therapy Product Offered
Table 106. Qingdao Phagepharm Bio-tech Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 107. Qingdao Phagepharm Bio-tech Main Business
Table 108. Qingdao Phagepharm Bio-tech Latest Developments
Table 109. Fixed-Phage Limited Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 110. Fixed-Phage Limited Phage Therapy Product Offered
Table 111. Fixed-Phage Limited Main Business
Table 112. Fixed-Phage Limited Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 113. Fixed-Phage Limited Latest Developments
Table 114. Zeptometrix Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 115. Zeptometrix Phage Therapy Product Offered
Table 116. Zeptometrix Main Business
Table 117. Zeptometrix Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 118. Zeptometrix Latest Developments
Table 119. Phage International, Inc. Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 120. Phage International, Inc. Phage Therapy Product Offered
Table 121. Phage International, Inc. Main Business
Table 122. Phage International, Inc. Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 123. Phage International, Inc. Latest Developments
Table 124. MicroMir Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 125. MicroMir Phage Therapy Product Offered
Table 126. MicroMir Main Business
Table 127. MicroMir Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 128. MicroMir Latest Developments
Table 129. iNtODEWORLD, Inc. Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 130. iNtODEWORLD, Inc. Phage Therapy Product Offered
Table 131. iNtODEWORLD, Inc. Main Business
Table 132. iNtODEWORLD, Inc. Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 133. iNtODEWORLD, Inc. Latest Developments
Table 134. NEXTBIOTICS Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 135. NEXTBIOTICS Phage Therapy Product Offered
Table 136. NEXTBIOTICS Main Business
Table 137. NEXTBIOTICS Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 138. NEXTBIOTICS Latest Developments
Table 139. Armata Pharmaceuticals, Inc. Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 140. Armata Pharmaceuticals, Inc. Phage Therapy Product Offered
Table 141. Armata Pharmaceuticals, Inc. Main Business
Table 142. Armata Pharmaceuticals, Inc. Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 143. Armata Pharmaceuticals, Inc. Latest Developments
Table 144. Innophage Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 145. Innophage Phage Therapy Product Offered
Table 146. Innophage Main Business
Table 147. Innophage Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 148. Innophage Latest Developments
Table 149. Adaptive Phage Therapeutics Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 150. Adaptive Phage Therapeutics Phage Therapy Product Offered
Table 151. Adaptive Phage Therapeutics Main Business
Table 152. Adaptive Phage Therapeutics Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 153. Adaptive Phage Therapeutics Latest Developments
Table 154. TechnoPhage Details, Company Type, Phage Therapy Area Served and Its Competitors
Table 155. TechnoPhage Phage Therapy Product Offered
Table 156. TechnoPhage Phage Therapy Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 157. TechnoPhage Main Business
Table 158. TechnoPhage Latest Developments
List of Figures
Figure 1. Phage Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Phage Therapy Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Phage Therapy Market Size Market Share by Type in 2020
Figure 7. Phage Therapy in Animal Health
Figure 8. Global Phage Therapy Market: Animal Health (2016-2021) & ($ Millions)
Figure 9. Phage Therapy in Aquaculture
Figure 10. Global Phage Therapy Market: Aquaculture (2016-2021) & ($ Millions)
Figure 11. Phage Therapy in Agriculture
Figure 12. Global Phage Therapy Market: Agriculture (2016-2021) & ($ Millions)
Figure 13. Phage Therapy in Food Industry
Figure 14. Global Phage Therapy Market: Food Industry (2016-2021) & ($ Millions)
Figure 15. Phage Therapy in Human Health
Figure 16. Global Phage Therapy Market: Human Health (2016-2021) & ($ Millions)
Figure 17. Phage Therapy in Others
Figure 18. Global Phage Therapy Market: Others (2016-2021) & ($ Millions)
Figure 19. Global Phage Therapy Market Size Market Share by Application in 2020
Figure 20. Global Phage Therapy Revenue Market Share by Player in 2020
Figure 21. Global Phage Therapy Market Size Market Share by Regions (2016-2021)
Figure 22. Americas Phage Therapy Market Size 2016-2021 ($ Millions)
Figure 23. APAC Phage Therapy Market Size 2016-2021 ($ Millions)
Figure 24. Europe Phage Therapy Market Size 2016-2021 ($ Millions)
Figure 25. Middle East & Africa Phage Therapy Market Size 2016-2021 ($ Millions)
Figure 26. Americas Phage Therapy Market Size Market Share by Country in 2020
Figure 27. Americas Phage Therapy Market Size Market Share by Type in 2020
Figure 28. Americas Phage Therapy Market Size Market Share by Application in 2020
Figure 29. United States Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 30. Canada Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 31. Mexico Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 32. APAC Phage Therapy Market Size Market Share by Regions in 2020
Figure 33. APAC Phage Therapy Market Size Market Share by Type in 2020
Figure 34. APAC Phage Therapy Market Size Market Share by Application in 2020
Figure 35. China Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 36. Japan Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 37. Korea Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 38. Southeast Asia Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 39. India Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 40. Australia Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 41. Europe Phage Therapy Market Size Market Share by Country in 2020
Figure 42. Europe Phage Therapy Market Size Market Share by Type in 2020
Figure 43. Europe Phage Therapy Market Size Market Share by Application in 2020
Figure 44. Germany Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 45. France Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 46. UK Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 47. Italy Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 48. Russia Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 49. Middle East & Africa Phage Therapy Market Size Market Share by Region in 2020
Figure 50. Middle East & Africa Phage Therapy Market Size Market Share by Type in 2020
Figure 51. Middle East & Africa Phage Therapy Market Size Market Share by Application in 2020
Figure 52. Egypt Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 53. South Africa Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 54. Israel Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 55. Turkey Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 56. GCC Country Phage Therapy Market Size Growth 2016-2021 ($ Millions)
Figure 57. Americas Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 58. APAC Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 59. Europe Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 60. Middle East & Africa Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 61. United States Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 62. Canada Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 63. Mexico Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 64. Brazil Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 65. China Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 66. Japan Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 67. Korea Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 68. Southeast Asia Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 69. India Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 70. Australia Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 71. Germany Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 72. France Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 73. UK Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 74. Italy Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 75. Russia Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 76. Spain Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 77. Egypt Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 78. South Africa Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 79. Israel Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 80. Turkey Phage Therapy Market Size 2021-2026 ($ Millions)
Figure 81. GCC Country Phage Therapy Market Size 2021-2026 ($ Millions)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs